دانشکده داروسازی-School Of Pharmacy- كلية الصيدلة

23. Hadizadeh, F.,Seifi, M. (2009)An efficient method for seperation . International Symposium on Saffron a Herbal Medicine of 3rd Millennium. 13-14 May, Mashhad, Iran.

24.Hadizadeh, F.,Malaekeh-Nikouei, B.,Seyed Mohammadi, S.R.,Seifi, M. (2009) Synthesis of PEGylated Fatty Acids as Solid Lipid Nanoparticle (SLN) Carrier for Targeted Lipospheres. The specialized congress of Nanomedicine, Nanobiotechnology, Nanobiosensors and nanomaterials, Summer, Mashhad , Iran

25. Hadizadeh,F. Khodaverdi, E., Jalali, A., Seifi, M., (2009) Preparation of thermosensitive PLGA-PEG-PLGA Tri-Block Copolymers as Controlled Drug Delivery systems. ICRC, Zangan, Iran

26.Hadizadeh, F., Jaafarpour, M. (2009)Quantitative structure activity relationship of 4-imidazolyl 1,4-dihydropyridines. 2nd congress of mathematics optional control in medicine. Mashhad, Iran

27.Hadizadeh, F., Khodaverdi, E., Honaramandi-Shandiz, R. (2010) Synthetic Zeolites for drug delivery. 2nd Iran International Zeolite Conference, April 29-30, Tehran, Iran

28. Hadizadeh.F, Entezari-Heravi.R , Behravan.J , seifi.M. (2010) Synthesis of four new analogous of 4,5-diaryl-imidazolyl-imidazole as selective COX-II inhibitors and anticancer, Iranian Pharmaceutical Sciences Conference (IPSC) August 2-5 , Zanjan, Iran

29. Badieyan, Z., Hadizadeh,F.(2010) Searching for novel cyclooxygenase II inhibitors by virtual screening and evaluating their inhibitory effects on cyclooxygenase II activity. Iranian Pharmaceutical Sciences Conference (IPSC) August 2-5 , Zanjan, Iran

30.Hadizadeh, F., Khodaverdi, E., Tafaghodi, M., Beizai, S. (2011) Preparation insulin nanospheresfrom thermosensitive PLGA-PEG-PLGA Polymer . 1st nanodrugs congress, Ahwaz, Esfand 89

31. Farzin Hadizadeh, Kiarash Ghazvini,Sepideh Eskenati. (2011) In vitro evaluation of antimycobacterial activity of N-aryl-1,4-dihydro pyridine-3,5-dicarboxamides against Mycobacterium bovis BCG 1st International and 12th Iranian Congrss of Microbiology. Kermanshah 23-26May.

32. Farzin hadizadeh, Isa Yavar, Seyed Adel Moallem (2011) New N-aryl-4-methylsulfonylamino benzenesulfonamides as selective COX-2 inhibitors , 12 Iranian Congrss of Biochemistry and 4th International Congrss of Biochemistry and Molecular Biochemistry and Molecular Biology, Mashhad, Iran september 6-9. published in Clinical Biochemistry vol 44 No 13S, 2011.

33. Farzin Hadizadeh, Seyed Adel Moallem, Fatemeh Abdolabadi, Mahmoud Shahraki. (2011) Synthesis and evaluation of pyridinyltriazoles as inhibitors of p38 MAP kinase . 7th National Biotechnology Congress of I.R. Iran , 12-14 September, Niroo Research Institute, Tehran

34. Farzin Hadizadeh, Elham Khodaverdi, Ali Golmohammadian , Arsalan Akbari (2011) Biodegradable in situ gel-forming controlled drug delivery system based biodegradable thermosensitive PCL–PEG–PCL hydrogel . The 5th Iranian Controlled Release Conference (ICRC). Mashhad , 4-6 october,Iran

35. Mehrnaz Jafarpour , Saadat,Vahdani, Farzin Hadizadeh. Quantitative Structure Activity Relationship Studies of 4-Imidazolyl-1,4-dihydropyridines as Calcium Channel Blockers. 3^rd National Conference on the Application of Mathematics and Control Theory in Medical Sciences, BioMath 2011, Azad University, Bojnord.

36. Ali Imani, Mohammad Ramezani, Farzin hadizadeh*. (2012) Preparation of nanosilica particles as gene delivery carrier. Second nanodrugs congress,Joundishapour University of Medical Sciences, Ahwaz. 16-18 Esfand.

37.F. Hadizadeh*, S. Moallem, F. Abdol Abadi, M. Shahraki (2012)Synthesis and evaluation of pyridinyltriazoles as inhibitors of p38 MAP kinase 13th Iranian Pharmaceutical Sciences Congress, Isfahan

38.M. Rameshrad*, F. Hadizadeh, S. Moallem (2012) Immunosuppressant effects of novel imidazolyl leflunomide analogues: In vitro determination of IFN-gamma in human lymphocyte culture 13th Iranian Pharmaceutical Sciences Congress, Isfahan

39 F. Hadizadeh, N. Shahini* (2012) Synthesis of cyclooxygenase inhibitor 2-(1-benzyl-alkyl thio-5-imidazolyl)-3-pheenyl-1, 3-thiazolidin-4-one as anticancer agent. 13th Iranian Pharmaceutical Sciences Congress, Isfahan

40.Sayyed A. Sajadi Tabassi*, E. Khodaverdi, F. Hadizadeh, R. Rashid(2012) Preparation of hydrogels based on inclusion complexes of the triblock copolymer PCL-PEG-PCL with α-cyclodextrin (α-CD)13th Iranian Pharmaceutical Sciences Congress, Isfahan

41.Zandhzaghighi, M., Ghazvini, k., Meshkat, Z., Hadizadeh, F.*(2012) In vitro cytotoxicity activity of new anti-TB drugs against Hela, Raji, Kga-1 and mouse lymphocyte primary cell lines. 6ICCM, Mashhad

42. Seifi, M., Hadizadeh, F. (2012) Isolation of lycopene from tomato paste using ursodesoxycholic acid as inclusve agent , National conference of natural products and medicinal plants. Bojnord University of Medical Sciences

43.Moallem, S.A.,Hadizadeh, F., Abdol-Abadi, F.,Shahraki, M., Shamsara, J.(2012) In silico and in vivo evaluation of pyridinyltriazoles as P38 MAP kinase inhibitors. The fourth Iranian Conference on Bioinformatics . 6-7 november. Karaj.

44. Farzin Hadizadeh, Mona Alibolandi.(2013) Highly luminescence, microwave assisted synthesis of water soluble carboxylic acid-functionalized CdTe Quantum Dots. 19th Iranian Seminar of Analytical chemistry 26-28 Feb. Mashhad, Ferdowsi University

45. Hadizadeh F, Zand Haghighi M, Ghazvini K, Derakhshan M , Meshkat Z(2013) Cytotoxicity Evaluation of new Derivatives of N-aryl-1,4-dihydropyridine-3,5-dicarboxamides on HELA, RAJI, KG-1a and MOUSE LYMPHOCYTE primary Cell lines. 12th Iranian Congress of Toxicology 15-17 May Sari

46. Mohsen Imenshahidi, Milad Alipour, Farzin Hadizadeh (2013) Hypotensive effect of of a Novel Dihydropyridine as Dual Calcium Channel Blocker and Angiotensin Antagonist in rats. 21st International congress of physiology and pharmacology. tabriz

47. Hadizadeh F, Zand Haghighi M, Ghazvini K, Derakhshan M, Meshkat Z. (2013) Cytotoxicity of new anti tuberculosis N-aryl-1,4-dihydropyridine-3,5-dicarboxamides on HELA, RAJI, KG-1a and MOUSE LYMPHOCYTE primary Cell lines 7th international Iranian congress of clinical Microbiology 19-23 october, Shiraz

فعالیتهای تحقیقاتی دکتر فرزین هادی زاده

دانشکده داروسازی دانشگاه علوم پزشکی مشهد